Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quick Listen: Scrip’s Five Must-Know Things

Executive Summary

Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things. 

This episode looks at the big stories as reported by Scrip's global team for the business week ended 27 November 2020. 

On the menu this time are further developments with coronavirus vaccines, big pharma efforts to showcase and continue R&D amid the pandemic, and an alliance change in the cardiovascular area.

 

 

Stories mentioned in this episode:

(Also see "A Stroke Of Luck Boosts Oxford/AZ’s “Vaccine For The World”" - Scrip, 24 Nov, 2020.)

(Also see "Novartis CEO Touts R&D 'Wild Cards' As Proof Of Deep Pipeline" - Scrip, 25 Nov, 2020.)

(Also see "Sanofi Grapples With Pandemic, Growing Clinical Trials, Implementing Acquisitions" - Scrip, 24 Nov, 2020.)

(Also see "Amgen Hands Omecamtiv Back To Cytokinetics" - Scrip, 23 Nov, 2020.)

(Also see "Pfizer And Moderna’s Cold War On COVID Gets Competitive" - Scrip, 19 Nov, 2020.)

These and all Informa Pharma Intelligence podcasts are available on SoundCloud, Apple Podcasts, TuneIn and Google Play and also via smart speakers - just make sure one of these providers is set up as your default for podcasts, and then ask for "Pharma Intelligence podcasts".

Related Content

Topics

UsernamePublicRestriction

Register

SC143395

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel